Menu
image description

Tag: GSK

Promising News from Major Medical Meeting, EULAR

Updated June 5, 2020 One of the largest meetings for rheumatologists went virtual this year to enable scientists from around the world to share their latest findings amid the COVID-19 pandemic. EULAR, the e-Congress of the European League Against Rheumatism, runs June 3 -6, and LRA is pleased to share promising results from clinical trials […] Read More

Northern Michigan – Frankfort Walk with Us to Cure Lupus

The 2020 Northern Michigan – Frankfort Walk with Us to Cure Lupus presented by GSK is the Lupus Research Alliance’s national fundraising program. The Lupus Research Alliance is the largest private sector organization dedicated to advancing lupus research. Walk distance is approximately 5k (3.1 miles) Contact Amy Gillard at ajgillard@lupusresearch.org or at 231-313-4758. Register Now […] Read More

Research Shows Benefit to Starting Belimumab Sooner Rather Than Later

April 16, 2020 Treating people with lupus earlier with belimumab (Benlysta) may work better than as a last option according to a study just published in the well-respected journal Arthritis & Rheumatology  Researchers in Italy analyzed data from 466 people with lupus at 24 centers in Italy who were receiving belimumab intravenously.  They looked at […] Read More

Wichita Walk with Us to Cure Lupus

The 2020 Wichita Walk with Us to Cure Lupus presented by GSK is the Lupus Research Alliance’s national fundraising program. The Lupus Research Alliance is the largest private sector organization dedicated to advancing lupus research. Walk distance is approximately 5k (3.1 miles) Contact Joanna Zelkowska at lupuswalkwichita@lupusresearch.org or at 646-884-6014. Register Now ►   Read More

Mid-Atlantic Walk with Us to Cure Lupus

The 2020 Mid-Atlantic Walk with Us to Cure Lupus presented by GSK is the Lupus Research Alliance’s national fundraising program. The Lupus Research Alliance is the largest private sector organization dedicated to advancing lupus research. Walk distance is approximately 5k (3.1 miles) Contact Joanne Golombos at jgolombos@lupusresearch.org or at 732-610-2267 . Register Now ►   Read More

Chicago Walk with Us to Cure Lupus

The 2020 Chicago Walk with Us to Cure Lupus presented by GSK is the Lupus Research Alliance’s national fundraising program. The Lupus Research Alliance is the largest private sector organization dedicated to advancing lupus research. Walk distance is approximately 5k (3.1 miles) Contact Maddy Bustamante at mbustamante@lupusresearch.org or at 646-884-6030. Register Now ►   Read More

New Jersey Walk with Us to Cure Lupus

The 2020 New Jersey Walk with Us to Cure Lupus presented by GSK is the Lupus Research Alliance’s national fundraising program. The Lupus Research Alliance is the largest private sector organization dedicated to advancing lupus research. Walk distance is approximately 5k (3.1 miles) Contact Joanne Golombos at jgolombos@lupusresearch.org or at 732-610-2267. Register Now ►   Read More

South Florida Walk with Us to Cure Lupus

The 2020 South Florida Walk with Us to Cure Lupus presented by GSK is the Lupus Research Alliance’s national fundraising program. The Lupus Research Alliance is the largest private sector organization dedicated to advancing lupus research. Walk distance is approximately 5k (3.1 miles) Contact Jonathan Marks or Madeline Bustamante at lupuswalksouthflorida@lupusresearch.org or at 646-884-6030. Register […] Read More

Los Angeles Walk with Us to Cure Lupus

The 2020 Los Angeles Walk with Us to Cure Lupus presented by GSK is the Lupus Research Alliance’s national fundraising program. The Lupus Research Alliance is the largest private sector organization dedicated to advancing lupus research. Walk distance is approximately 5k (3.1 miles) Contact Carla Calavitta at ccalavitta@lupusresearch.org@lupusresearch.org or at 646-884-6041. Register Now ►   Read More

LRA Shares Excitement For What’s Ahead in Lupus Nephritis

January 16, 2020 Up to half of people with lupus will have lupus nephritis – damage to the kidneys that affects the ability to clear the body of wastes and toxins. In 2020, we expect to see significant progress in new drug development for lupus and lupus nephritis in particular with submissions for FDA approval in […] Read More